Literature DB >> 17444844

New hepatitis C guidelines for the Asia-Pacific region: APASL consensus statements on the diagnosis, management and treatment of hepatitis C virus infection.

Geoffrey C Farrell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17444844     DOI： 10.1111/j.1440-1746.2007.04969.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN： 0815-9319            Impact factor:   4.029


× No keyword cloud information.
  8 in total

1.  Comparative proteomic study reveals 17β-HSD13 as a pathogenic protein in nonalcoholic fatty liver disease.

Authors:  Wen Su; Yang Wang; Xiao Jia; Wenhan Wu; Linghai Li; Xiaodong Tian; Sha Li; Chunjiong Wang; Huamin Xu; Jiaqi Cao; Qifei Han; Shimeng Xu; Yong Chen; Yanfeng Zhong; Xiaoyan Zhang; Pingsheng Liu; Jan-Åke Gustafsson; Youfei Guan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-15       Impact factor: 11.205

2.  Hepatocellular carcinoma in Asia: Prevention strategy and planning.

Authors:  Sara Ashtari; Mohamad Amin Pourhoseingholi; Afsaneh Sharifian; Mohamad Reza Zali
Journal:  World J Hepatol       Date:  2015-06-28

3.  10-year trends in the diagnosis and treatment of hepatitis C and concomitant mental health disorders: 1995 to 2005.

Authors:  Barbara P Yawn; Liliana Gazzuola Rocca; Peter C Wollan
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

4.  On-treatment predictions of success in peg-interferon/ribavirin treatment using a novel formula.

Authors:  Hidetsugu Saito; Hirotoshi Ebinuma; Keisuke Ojiro; Kanji Wakabayashi; Mika Inoue; Shinichiro Tada; Toshifumi Hibi
Journal:  World J Gastroenterol       Date:  2010-01-07       Impact factor: 5.742

5.  Treatment Response and Tolerability of Pegylated Interferon-α Plus Ribavirin Combination Therapy in elderly Patients (≥ 65 years) With Chronic Hepatitis C in Korea.

Authors:  Hyeong Il Kim; In Hee Kim; Byung Jun Jeon; Seok Lee; Seong Hun Kim; Sang Wook Kim; Seung Ok Lee; Soo Teik Lee; Dae Ghon Kim
Journal:  Hepat Mon       Date:  2012-07-30       Impact factor: 0.660

Review 6.  Expert opinion on the treatment of patients with chronic hepatitis C.

Authors:  S Zeuzem; T Berg; B Moeller; H Hinrichsen; S Mauss; H Wedemeyer; C Sarrazin; D Hueppe; E Zehnter; M P Manns
Journal:  J Viral Hepat       Date:  2008-08-28       Impact factor: 3.728

7.  Application of zero-inflated poisson mixed models in prognostic factors of hepatitis C.

Authors:  Alireza Akbarzadeh Baghban; Asma Pourhoseingholi; Farid Zayeri; Ali Akbar Jafari; Seyed Moayed Alavian
Journal:  Biomed Res Int       Date:  2013-10-01       Impact factor: 3.411

8.  Random effect model for identifying related factors to virological response in HCV patients.

Authors:  Farid Zayeri; Samira Chaibakhsh; Asma Pourhoseingholi; Alireza Akbarzadeh Baghban; Seyed Moayed Alavian
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.